Main Menu

Making the discoveries that defeat cancer

The Institute of Cancer Research is one of the world’s most influential cancer research organisations. We are a UK charity and member institution of the University of London.

“There was a lot of joy, and a lot of living got done”

Hilary Morgan kindly shared the story of her husband, Tim, to support our bowel cancer fundraising appeal. Tim was diagnosed with advanced bowel cancer at the age of 43. Here, Hilary tells us more about how pioneering treatments gave him a chance to live.
Read more
Trial shows benefits of targeted drug against early-stage breast cancer with inherited BRCA mutation

Women with high-risk, early-stage breast cancer who also have inherited faults in their BRCA1 or BRCA2 genes have shown a remarkable response to the targeted drug olaparib in a major clinical trial.
Read more
Help us develop smarter treatments for bowel cancer patients

Bowel cancer patients urgently need new treatment options. Your support will help bring us one step closer to more effective immunotherapy treatments for bowel cancer - and give these patients the chance to finish what they started.
Read more
ICR announces new Chair of Board of Trustees

Professor Julia Buckingham CBE, an acclaimed medical researcher with exceptional leadership experience in academic institutions and across the sector, will become Chair in August.
Read more

1/4

Making it count

We will deliver better outcomes and quality of life for patients by establishing innovative treatments, diagnostics and prevention strategies as part of routine healthcare.
Improving patient lives
Queen's Anniversary Prize

The ICR has been recognised with a prestigious Queen’s Anniversary Prize for its world-leading research in cancer drug discovery.
Queen's Anniversary Prize
Unravelling cancer’s complexity

We will comprehend the full complexity of cancer by harnessing the power of new technologies and Big Data.
Big data research
Smarter, kinder treatments

We will move a step closer to cure by bringing personalised treatments into the clinic and developing them for patients.
Personalised treatments
Creating new treatments that target tumours

Teams of biologists, chemists and computational scientists design new drugs to selectively attack tumours.
About drug discovery
Innovative approaches

We will take on the challenge of cancer’s complexity, evolution and drug resistance through the discovery of innovative new approaches to cancer treatment.
Our innovative approaches